XML 26 R28.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue Recognition (Tables)
 3 Months Ended
Mar. 28, 2020
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
We generated net sales in the following geographic locations(1) (in millions):
 
Three Months Ended
 
March 28,
2020
 
March 30,
2019
U.S.
$
901.6

 
$
768.8

Europe(2)
372.6

 
340.9

All other countries(3)
66.8

 
64.8

Total net sales
$
1,341.0

 
$
1,174.5


(1) Derived from the location of the entity that sells to a third party.
(2) Includes Ireland net sales of $3.8 million and $5.2 million for the three months ended March 28, 2020 and March 30, 2019, respectively.
(3) Includes net sales generated primarily in Israel, Mexico, Australia and Canada.

Product Category

We re-aligned our product categories in our CSCA and CSCI segments as of December 31, 2019. The re-alignment standardizes our categories and product level detail to provide consistency. This transformative step will optimize the way in which management reports and evaluates our business.

    
The following is a summary of our net sales by category (in millions); the comparative period reflects the product category re-alignment:
 
Three Months Ended
 
March 28,
2020
 
March 30,
2019
CSCA(1)
 
 
 
Upper respiratory
$
154.6

 
$
132.8

Pain and sleep-aids
120.4

 
91.3

Digestive health
106.9

 
102.3

Nutrition
102.2

 
99.6

Healthy lifestyle
85.8

 
76.0

Oral self-care
55.3

 
—

Skincare and personal hygiene
46.7

 
45.5

Vitamins, minerals, and supplements
6.4

 
6.3

Animal health
—

 
19.6

Other CSCA(2)
22.3

 
8.4

Total CSCA
700.6

 
581.8

CSCI
 
 
 
Skincare and personal hygiene
94.7

 
101.9

Upper respiratory
84.1

 
71.9

Vitamins, minerals, and supplements
48.5

 
45.8

Pain and sleep-aids
46.8

 
40.4

Healthy lifestyle
43.6

 
47.3

Oral self-care
23.2

 
1.6

Digestive health
6.0

 
7.2

Other CSCI(3)
35.8

 
34.7

Total CSCI
382.7

 
350.8

RX
257.7

 
241.9

Total net sales
$
1,341.0

 
$
1,174.5


(1)    Includes net sales from our OTC contract manufacturing business.
(2)
Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.    
(3)
Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
Contract with Customer Balances
The following table provides information about contract assets from contracts with customers (in millions):
 
Balance Sheet Location
 
March 28,
2020
 
December 31,
2019
Short-term contract assets
Prepaid expenses and other current assets
 
$
28.1

 
$
26.3